secwatch.observer — SEC 8-K summary
======================================

Issuer:     Heartflow, Inc. (HTFL)
CIK:        0001464521
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001464521-25-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heartflow Q3 revenue $46.3M (+41% YoY); initiates FY2025 guidance $173.0M-$173.5M
--------------------------------------------------------------------------------

- Net loss $50.9M ($1.04/share) includes $32.1M warrant remeasurement; non-GAAP net loss $13.2M ($0.27/share).
- Gross margin 76.5% (non-GAAP 76.8%); net operating loss $15.1M (non-GAAP $11.1M).
- UnitedHealthcare and Cigna began covering Heartflow Plaque Analysis on Oct 1, 2025.
- IPO raised ~$364.2M in gross proceeds; cash $291.2M at Sept 30 after debt repayments.
- Full year 2025 revenue guidance $173.0M-$173.5M; warrants fully exercised post-quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1464521/000146452125000018/0001464521-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1464521/000146452125000018/htfl-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001464521-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer